| Schedule of quantitative impact of the changes on financials |
The quantitative impact of the changes on the statement of operations for the three months ended March 31, 2018 are set out below (in thousands):
|
|
|
Under previous
revenue
guidance
|
|
Adjustment
|
|
As reported
|
|
|
|
|
|
|
|
|
|
|
|
Revenue
|
|
$
|
8,996
|
|
$
|
(800
|
)
|
$
|
8,196
|
|
|
Operating loss
|
|
(27,940
|
)
|
(800
|
)
|
(28,740
|
)
|
|
Loss before income taxes
|
|
(20,151
|
)
|
(800
|
)
|
(20,951
|
)
|
|
Net loss attributable to ordinary shareholders
|
|
(20,278
|
)
|
(800
|
)
|
(21,078
|
)
|
The quantitative impact of the changes on the balance sheet as of March 31, 2018 are set out below (in thousands):
|
|
|
Under previous
revenue
guidance
|
|
Adjustment
|
|
As reported
|
|
|
|
|
|
|
|
|
|
|
|
Deferred revenue
|
|
$
|
35,066
|
|
$
|
(7,845
|
)
|
$
|
27,221
|
|
|
Total current liabilities
|
|
59,767
|
|
(7,845
|
)
|
51,922
|
|
|
Total liabilities
|
|
63,651
|
|
(7,845
|
)
|
55,806
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated deficit
|
|
(251,908
|
)
|
7,845
|
|
(244,063
|
)
|
|
Total stockholders’ equity
|
|
183,417
|
|
7,845
|
|
191,262
|
|
The quantitative impact of the changes on the statement of cashflows for the three months ended March 31, 2018 are set out below (in thousands):
|
|
|
Under previous
revenue
guidance
|
|
Adjustment
|
|
As reported
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
$
|
(20,278
|
)
|
$
|
(800
|
)
|
$
|
(21,078
|
)
|
|
Decrease in payables and deferred revenue
|
|
(16,679
|
)
|
800
|
|
(15,879
|
)
|
|